Anti-EBV Latent Membrane Protein 1 [CS 1-4]

Datasheet

Reviews (0)

Info

Catalogue Number	151471
Applications	IHC IF IP WB
Antigen/Gene or Protein Targets	Epstein-Barr Virus, Latent Membrane Protein 1 (EBV-LMP1)
Reactivity	Virus
Relevance	EBV is a human herpesvirus that establishes a life-long persistence in the host. The virus infects the vast majority of the world's adult population and is well known for its association with a broad spectrum of benign and malignant diseases, including infectious mononucleosis, Burkitt's lymphoma, nasopharyngeal carcinoma, and is causally associated with lymphoid and epithelial malignancies, including post-transplant lymphoproliferative disorders, Hodgkin's disease, anaplastic nasopharyngeal carcinoma and gastric carcinomas. Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is a transforming protein that affects multiple cell signalling pathways and contributes to EBV-associated oncogenesis. LMP1 can be expressed in some states of EBV latency, and significant induction of full-length LMP1 is also observed frequently during virus reactivation into the lytic cycle. LMP1 is critical for EBV-infected cell activation, adhesion and survival, and is usually expressed in the malignant cells. CS 1-4 is specific for Epstein-Barr virus infected cells expressing the latent membrane protein (LMP). This antibody is four pooled monoclonal antibodies that collectively detect LMP's encoded by each of 20 geographically distinct EBV isolates.
Host	Mouse
Subclass	IgG1
Positive Control	EBV transformed lymphoblastoid cell lines
Molecular Weight (kDa)	57-66
Myeloma Used	P3X63Ag8.653
Research Area	Adhesion, Cancer, Cell Signaling & Signal Transduction, Immunology, Virology